| Product Code: ETC12125167 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Israel continued to see a steady flow of erlotinib hydrochloride tablet imports, with top exporting countries being Switzerland, UK, Belgium, USA, and Germany. Despite the presence of key players, the market remained relatively competitive with a low Herfindahl-Hirschman Index (HHI) concentration. The compound annual growth rate (CAGR) from 2020 to 2024 experienced a decline of -2.14%, while the growth rate from 2023 to 2024 was -0.41%, indicating a slight contraction in the market. Israel`s reliance on these key exporting countries demonstrates a diverse import landscape for erlotinib hydrochloride tablets.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Exeter Erlotinib Hydrochloride Tablet Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, 2022 & 2032F |
3.3 Israel Exeter Erlotinib Hydrochloride Tablet Market - Industry Life Cycle |
3.4 Israel Exeter Erlotinib Hydrochloride Tablet Market - Porter's Five Forces |
3.5 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
3.6 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume Share, By Dosage Form, 2022 & 2032F |
3.7 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume Share, By Therapeutic Class, 2022 & 2032F |
3.8 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Israel Exeter Erlotinib Hydrochloride Tablet Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Israel Exeter Erlotinib Hydrochloride Tablet Market Trends |
6 Israel Exeter Erlotinib Hydrochloride Tablet Market, By Types |
6.1 Israel Exeter Erlotinib Hydrochloride Tablet Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Product Type, 2022 - 2032F |
6.1.3 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Erlotinib Tablets, 2022 - 2032F |
6.1.4 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Erlotinib 100mg Tablets, 2022 - 2032F |
6.1.5 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Erlotinib 150mg Tablets, 2022 - 2032F |
6.1.6 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Erlotinib 25mg Tablets, 2022 - 2032F |
6.2 Israel Exeter Erlotinib Hydrochloride Tablet Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Oral Tablets, 2022 - 2032F |
6.2.3 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By 100mg Tablets, 2022 - 2032F |
6.2.4 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By 150mg Tablets, 2022 - 2032F |
6.2.5 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By 25mg Tablets, 2022 - 2032F |
6.3 Israel Exeter Erlotinib Hydrochloride Tablet Market, By Therapeutic Class |
6.3.1 Overview and Analysis |
6.3.2 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By EGFR Inhibitors, 2022 - 2032F |
6.3.3 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Chemotherapy Drugs, 2022 - 2032F |
6.3.4 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Anticancer Medications, 2022 - 2032F |
6.3.5 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Chemotherapy Alternatives, 2022 - 2032F |
6.4 Israel Exeter Erlotinib Hydrochloride Tablet Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Cancer Patients, 2022 - 2032F |
6.4.3 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Non-small Cell Lung Cancer, 2022 - 2032F |
6.4.4 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Pancreatic Cancer Patients, 2022 - 2032F |
6.4.5 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Patients with Limited Treatment Options, 2022 - 2032F |
7 Israel Exeter Erlotinib Hydrochloride Tablet Market Import-Export Trade Statistics |
7.1 Israel Exeter Erlotinib Hydrochloride Tablet Market Export to Major Countries |
7.2 Israel Exeter Erlotinib Hydrochloride Tablet Market Imports from Major Countries |
8 Israel Exeter Erlotinib Hydrochloride Tablet Market Key Performance Indicators |
9 Israel Exeter Erlotinib Hydrochloride Tablet Market - Opportunity Assessment |
9.1 Israel Exeter Erlotinib Hydrochloride Tablet Market Opportunity Assessment, By Product Type, 2022 & 2032F |
9.2 Israel Exeter Erlotinib Hydrochloride Tablet Market Opportunity Assessment, By Dosage Form, 2022 & 2032F |
9.3 Israel Exeter Erlotinib Hydrochloride Tablet Market Opportunity Assessment, By Therapeutic Class, 2022 & 2032F |
9.4 Israel Exeter Erlotinib Hydrochloride Tablet Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Israel Exeter Erlotinib Hydrochloride Tablet Market - Competitive Landscape |
10.1 Israel Exeter Erlotinib Hydrochloride Tablet Market Revenue Share, By Companies, 2025 |
10.2 Israel Exeter Erlotinib Hydrochloride Tablet Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here